China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
China Resources Pharmaceutical Group Ltd., through its subsidiary CR Pharmaceutical Commercial, has issued RMB3 billion worth of perpetual bonds in the PRC, aimed at repaying existing corporate bonds. With a top-tier ‘AAA’ rating from China Chengxi International Credit Ratings, the bonds come in two varieties, offering a three-year term at 2.15% and a five-year term at 2.26% per annum.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
